Selected research
Market Structure
Global Buprenorphine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Buprenorphine Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Buprenorphine Hydrochloride Injection include Arevipharma, Faranshimi, Mallinckrodt, Micro Orgo Chem, Noramco, Resonance-labs, Rusan Pharma, Siegfried and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Buprenorphine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Buprenorphine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Buprenorphine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buprenorphine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Buprenorphine Hydrochloride Injection Segment by Company
Arevipharma
Faranshimi
Mallinckrodt
Micro Orgo Chem
Noramco
Resonance-labs
Rusan Pharma
Siegfried
Sun Pharma
Unichemlabs
Sanofi
Teva
Johnson Matthey
Buprenorphine Hydrochloride Injection Segment by Type
0.3mg / mL
0.6mg / mL
Buprenorphine Hydrochloride Injection Segment by Application
Analgesic
Opioid Antagonist
Buprenorphine Hydrochloride Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Buprenorphine Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Buprenorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Buprenorphine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Buprenorphine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.3mg / mL
- 0.6mg / mL
Applications
- Analgesic
- Opioid Antagonist
Companies covered
- Arevipharma
- Faranshimi
- Mallinckrodt
- Micro Orgo Chem
- Noramco
- Resonance-labs
- Rusan Pharma
- Siegfried
- Sun Pharma
- Unichemlabs
- Sanofi
- Teva
- Johnson Matthey
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Buprenorphine Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Buprenorphine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Buprenorphine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Buprenorphine Hydrochloride Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Buprenorphine Hydrochloride Injection Market Dynamics
- 2.1 Buprenorphine Hydrochloride Injection Industry Trends
- 2.2 Buprenorphine Hydrochloride Injection Industry Drivers
- 2.3 Buprenorphine Hydrochloride Injection Industry Opportunities and Challenges
- 2.4 Buprenorphine Hydrochloride Injection Industry Restraints
3 Buprenorphine Hydrochloride Injection Market by Manufacturers
- 3.1 Global Buprenorphine Hydrochloride Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Buprenorphine Hydrochloride Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Buprenorphine Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Buprenorphine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Buprenorphine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Buprenorphine Hydrochloride Injection Manufacturers, Product Type & Application
- 3.7 Global Buprenorphine Hydrochloride Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Buprenorphine Hydrochloride Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Buprenorphine Hydrochloride Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Buprenorphine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Buprenorphine Hydrochloride Injection Market by Type
- 4.1 Buprenorphine Hydrochloride Injection Type Introduction
- 4.1.1 0.3mg / mL
- 4.1.2 0.6mg / mL
- 4.2 Global Buprenorphine Hydrochloride Injection Sales by Type
- 4.2.1 Global Buprenorphine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Buprenorphine Hydrochloride Injection Sales by Type (2021-2032)
- 4.2.3 Global Buprenorphine Hydrochloride Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Buprenorphine Hydrochloride Injection Revenue by Type
- 4.3.1 Global Buprenorphine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Buprenorphine Hydrochloride Injection Revenue by Type (2021-2032)
- 4.3.3 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Buprenorphine Hydrochloride Injection Market by Application
- 5.1 Buprenorphine Hydrochloride Injection Application Introduction
- 5.1.1 Analgesic
- 5.1.2 Opioid Antagonist
- 5.2 Global Buprenorphine Hydrochloride Injection Sales by Application
- 5.2.1 Global Buprenorphine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Buprenorphine Hydrochloride Injection Sales by Application (2021-2032)
- 5.2.3 Global Buprenorphine Hydrochloride Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Buprenorphine Hydrochloride Injection Revenue by Application
- 5.3.1 Global Buprenorphine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Buprenorphine Hydrochloride Injection Revenue by Application (2021-2032)
- 5.3.3 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Buprenorphine Hydrochloride Injection Sales by Region
- 6.1 Global Buprenorphine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2032)
- 6.2.1 Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2026)
- 6.2.2 Global Buprenorphine Hydrochloride Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Buprenorphine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Buprenorphine Hydrochloride Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Buprenorphine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Buprenorphine Hydrochloride Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Buprenorphine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Buprenorphine Hydrochloride Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Buprenorphine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Buprenorphine Hydrochloride Injection Revenue by Region
- 7.1 Global Buprenorphine Hydrochloride Injection Revenue by Region
- 7.1.1 Global Buprenorphine Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Buprenorphine Hydrochloride Injection Revenue by Region (2021-2026)
- 7.1.3 Global Buprenorphine Hydrochloride Injection Revenue by Region (2027-2032)
- 7.1.4 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Buprenorphine Hydrochloride Injection Revenue (2021-2032)
- 7.2.2 North America Buprenorphine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Buprenorphine Hydrochloride Injection Revenue (2021-2032)
- 7.3.2 Europe Buprenorphine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Buprenorphine Hydrochloride Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Buprenorphine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Buprenorphine Hydrochloride Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Buprenorphine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Arevipharma
- 8.1.1 Arevipharma Company Information
- 8.1.2 Arevipharma Business Overview
- 8.1.3 Arevipharma Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio
- 8.1.5 Arevipharma Recent Developments
- 8.2 Faranshimi
- 8.2.1 Faranshimi Company Information
- 8.2.2 Faranshimi Business Overview
- 8.2.3 Faranshimi Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio
- 8.2.5 Faranshimi Recent Developments
- 8.3 Mallinckrodt
- 8.3.1 Mallinckrodt Company Information
- 8.3.2 Mallinckrodt Business Overview
- 8.3.3 Mallinckrodt Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio
- 8.3.5 Mallinckrodt Recent Developments
- 8.4 Micro Orgo Chem
- 8.4.1 Micro Orgo Chem Company Information
- 8.4.2 Micro Orgo Chem Business Overview
- 8.4.3 Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio
- 8.4.5 Micro Orgo Chem Recent Developments
- 8.5 Noramco
- 8.5.1 Noramco Company Information
- 8.5.2 Noramco Business Overview
- 8.5.3 Noramco Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Noramco Buprenorphine Hydrochloride Injection Product Portfolio
- 8.5.5 Noramco Recent Developments
- 8.6 Resonance-labs
- 8.6.1 Resonance-labs Company Information
- 8.6.2 Resonance-labs Business Overview
- 8.6.3 Resonance-labs Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio
- 8.6.5 Resonance-labs Recent Developments
- 8.7 Rusan Pharma
- 8.7.1 Rusan Pharma Company Information
- 8.7.2 Rusan Pharma Business Overview
- 8.7.3 Rusan Pharma Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio
- 8.7.5 Rusan Pharma Recent Developments
- 8.8 Siegfried
- 8.8.1 Siegfried Company Information
- 8.8.2 Siegfried Business Overview
- 8.8.3 Siegfried Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Siegfried Buprenorphine Hydrochloride Injection Product Portfolio
- 8.8.5 Siegfried Recent Developments
- 8.9 Sun Pharma
- 8.9.1 Sun Pharma Company Information
- 8.9.2 Sun Pharma Business Overview
- 8.9.3 Sun Pharma Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio
- 8.9.5 Sun Pharma Recent Developments
- 8.10 Unichemlabs
- 8.10.1 Unichemlabs Company Information
- 8.10.2 Unichemlabs Business Overview
- 8.10.3 Unichemlabs Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio
- 8.10.5 Unichemlabs Recent Developments
- 8.11 Sanofi
- 8.11.1 Sanofi Company Information
- 8.11.2 Sanofi Business Overview
- 8.11.3 Sanofi Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sanofi Buprenorphine Hydrochloride Injection Product Portfolio
- 8.11.5 Sanofi Recent Developments
- 8.12 Teva
- 8.12.1 Teva Company Information
- 8.12.2 Teva Business Overview
- 8.12.3 Teva Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Teva Buprenorphine Hydrochloride Injection Product Portfolio
- 8.12.5 Teva Recent Developments
- 8.13 Johnson Matthey
- 8.13.1 Johnson Matthey Company Information
- 8.13.2 Johnson Matthey Business Overview
- 8.13.3 Johnson Matthey Buprenorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio
- 8.13.5 Johnson Matthey Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Buprenorphine Hydrochloride Injection Value Chain Analysis
- 9.1.1 Buprenorphine Hydrochloride Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Buprenorphine Hydrochloride Injection Production Mode & Process
- 9.2 Buprenorphine Hydrochloride Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Buprenorphine Hydrochloride Injection Distributors
- 9.2.3 Buprenorphine Hydrochloride Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst